[1]
|
Wakao, F., Nishimoto, H., Katanoda, K., Tsukuma, H. and Mikami, H. (2013) Cancer Statistics in Japan, 2013. National Cancer Center.
|
[2]
|
Fujimoto, Y., Nakanishi, Y., Sekine, S., Yoshimura, K., Akasu, T., et al. (2005) CD10 Expression in Colorectal Carcinoma Correlates with Liver Metastasis. Diseases of the Colon & Rectum, 48, 1883-1889.
https://doi.org/10.1007/s10350-005-0141-6
|
[3]
|
Fong, Y., Kemeny, N., Paty, P., Blumgart, L.H. and Cohen, A.M. (1996) Treatment of Colorectal Cancer: Hepatic Metastasis. Seminars in Surgical Oncology, 12, 219-252.
https://doi.org/10.1002/(SICI)1098-2388(199607/08)12:4<219::AID-SSU3>3.0.CO;2-8
|
[4]
|
Shipp, M.A., Vi-jayaraghavan, J., Schmidt, E.V., Masteller, E.L., D’Adamio, L., et al. (1989) Common Acute Lymphoblastic Leukemia Antigen (CALLA) Is Active Neutral Endopeptidase 24.11 (“Enkephalinase”): Direct Evidence by cDNA Transfection Analysis. Proceedings of the National Academy of Sciences of the United States of America, 86, 297-301. https://doi.org/10.1073/pnas.86.1.297
|
[5]
|
Yao, T., Takata, M., Tustsumi, S., Nishiyama, K., Taguchi, K., et al. (2002) Phenotypic Expression of Gastrointestinal Differentiation Markers in Colorectal Adenocarcinomas with Liver Metastasis. Pathology, 34, 556-560.
https://doi.org/10.1080/0031302021000035965-4
|
[6]
|
Sasaki, T. (2014) Serum CD10 Is Associated with Liver Metastasis in Colorectal Cancer. Journal of Surgical Research, 192, 390-394. https://doi.org/10.1016/j.jss.2014.05.071
|
[7]
|
黄丽娜. CD276、CD133联合CEA、CA199在结直肠癌及其癌前疾病中的表达及意义[D]: [硕士学位论文]. 郑州: 郑州大学, 2018.
|
[8]
|
王天赐. 结直肠癌肝转移患者多因素预后分析[D]: [硕士学位论文]. 沈阳: 辽宁中医药大学, 2022.
|
[9]
|
傅志成. 血清CRP、白蛋白及GPS评分与大肠癌伴肝转移预后关系[J]. 安徽卫生职业技术学院学报, 2020, 19(3): 100-102.
|
[10]
|
Maeda, K., Shibutani, M., Otani, H., et al. (2015) Inflammation-Based Factors and Prognosis in Patients with Colorectal Cancer. World Journal of Gastrointestinal Oncology, 7, 111-117. https://doi.org/10.4251/wjgo.v7.i8.111
|
[11]
|
Køstner, A.H., Kersten, C., Löwenmark, T., Ydsten, K.A., Peltonen, R., Isoniemi, H., et al. (2016) The Prognostic Role of Systemic Inflammation in Patients Undergoing Resection of Colorectal Liver Metastases: C-Reactive Protein (CRP) Is a Strong Negative Prognos-tic Biomarker. Journal of Surgical Oncology, 114, 895-899.
https://doi.org/10.1002/jso.24415
|
[12]
|
王兆映, 李传涛, 庞青, 等. 炎症标志物对实体瘤预后价值的研究进展[J]. 齐齐哈尔医学院学报, 2020, 41(1): 84-87.
|
[13]
|
张瑜, 李亚, 吴海霞, 等. 血清CRP、白蛋白及GCS预后评分联合检测对结肠癌化疗疗效的预测意义[J]. 中国老年学杂志, 2015, 35(18): 5176-5178.
|
[14]
|
Gupta, D. and Lis, C.G. (2010) Pretreatment Serum Albumin as a Predictor of Cancer Survival: A Systematic Review of the Epidemiological Literature. Nutrition Journal, 9, Article No. 69. https://doi.org/10.1186/1475-2891-9-69
|
[15]
|
Virizuela, J.A., et al. (2018) Nutritional Support and Parenteral Nutrition in Cancer Patients: An Expert Consensus Report. Clinical and Translational Oncology, 20, 619-629. https://doi.org/10.1007/s12094-017-1757-4
|
[16]
|
龚兰, 吴瑜霞, 陈振宇, 等. GPS评分与结直肠癌预后的关系[J]. 检验医学与临床, 2016, 13(14): 1987-1989.
|
[17]
|
邱兴帅. 血清FIB、白蛋白、尿素氮联合CEA对结直肠癌的预测价值[D]: [硕士学位论文]. 恩施: 湖北民族大学, 2023.
|
[18]
|
李佳, 高佳, 崔婵娟, 等. 血清IV型胶原水平在结直肠癌肝转移中的应用价值[J]. 标记免疫分析与临床, 2021, 28(10): 1689-1692.
|
[19]
|
程晋坤, 沈杰, 邓科, 等. 术前AFR水平与同时性结直肠癌肝转移患者临床病理特征关系及预后分析[J]. 现代实用医学, 2021, 33(12): 1581-1584.
|
[20]
|
李道亮. 术前CRP、血脂、肿瘤标志物与结直肠癌病理分期及预后的相关性研究[D]: [硕士学位论文]. 海口: 海南医学院, 2022.
|
[21]
|
于建文. 纤维蛋白原和D-二聚体术前检测在结直肠癌诊疗中的应用价值[D]: [硕士学位论文]. 南昌: 南昌大学, 2023.
|
[22]
|
Sis, B., Sarioglu, S., Sokmen, S., et al. (2005) Desmoplasia Measured by Computer Assisted Image Analysis: An Independent Prognostic Marker in Colorectal Carcinoma. Journal of Clinical Pathology, 58, 32-38.
https://doi.org/10.1136/jcp.2004.018705
|
[23]
|
Baluk, P., Morikawa, S., Haskell, A., et al. (2003) Abnormalities of Basement Membrane on Blood Vessels and Endothelial Sprouts in Timors. The American Journal of Pathology, 163, 1801-1805.
https://doi.org/10.1016/S0002-9440(10)63540-7
|
[24]
|
白傲雪, 张宁苏, 董野, 等. 结直肠癌肝转移的相关因素[J]. 实用中医内科杂志, 2020, 34(5): 120-123.
|